Antipsikotik İlaçlar & Metabolik Yan Etkiler otik İlaçlar Yan Etkiler
Antipsikotik İlaçlar & Metabolik Yan Etkiler otik İlaçlar Yan Etkiler
Antipsikotik İlaçlar & Metabolik Yan Etkiler otik İlaçlar Yan Etkiler
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
9<br />
<strong>Metabolik</strong><br />
sendrom<br />
Bel çevresi Kan basıncı HDL AKŞ Trigliserit<br />
Base 3 ay Base 3 ay Base 3 ay Base 3 ay Base 3 ay Base 3 ay<br />
Olanzapin 41.9% 51.4% 36.5% 47.3% 49.3% 53.3% 47.3% 56.8% 35.1% 27.0% 48.7% 59.5%<br />
(n = 74) (n = 74) ( (n = 75) (n = 74) (n = 74) (n = 74)<br />
Risperidon 37.0% 42.6% 36.0% 42.0% 49.1% 49.1% 53.7% 59.3% 24.1% 37.0% 42.6% 33.3%<br />
(n = 54) (n = 50) ( (n = 53) (n = 54) (n = 54) (n = 54)<br />
Ketyapin 38.8% 43.3% 43.3% 49.3% 49.3% 53.7% 50.8% 52.2% 28.4% 32.8% 46.3% 47.8%<br />
(n = 67) (n = 67) ( (n = 67) (n = 67) (n = 67) (n = 67)<br />
Ziprasidon 48.4% 38.7% 43.3% 46.7% 41.4% 44.8% 56.3% 56.3% 25.0% 34.4% 53.1% 43.8%<br />
(n = 31) (n = 30) ( (n = 29) (n = 32) (n = 32) (n = 32)<br />
Perfenazin 42.3% 38.5% 42.0% 42.0% 48.1% 36.5% 54.7% 54.7% 26.4% 28.3% 47.2% 47.2%<br />
(n = 52) (n = 50) ( (n = 52) (n = 53) (n = 53) (n = 53)<br />
NS NS NS<br />
NS NS NS